Dr. Reddy's bulk manufacturing operations are spread across six units in Andhra Pradesh, India, a state-of-the-art facility in Mexico and a manufacturing site based in Mirfield, UK. These facilities have been built and are operated in accordance with the latest regulatory guidelines on cGMP. Our facilities have been inspected by the USFDA and numerous other international regulatory agencies for all major products.
A brief overview of our API manufacturing facilities.
Unit 1
- Set up in 1985
- Located at Bollaram, Hyderabad
- Has a Reaction Volume Capacity of 130
KL
- Is USFDA Inspected and ISO-9001
certified
|
|
Unit 2
- Set up in 1986
- Located at Bollaram, Hyderabad
- Has a Reaction Volume Capacity of 152
KL
- Is USFDA Inspected and ISO-9001
certified
|
|
Unit 3
- Set up in 1995
- Located at Bollaram, Hyderabad
- Has a Reaction Volume Capacity of 71 KL
- Is USFDA Inspected and ISO-9001
certified
|
|
Unit 4
- Set up in 1984
- Located at Jeedimetla, Hyderabad
- Has a Reaction Volume Capacity of 110
KL
- Is USFDA Inspected and ISO-9001
certified
|
 |
Unit 5
- Set up in 1987
- Located at Miriyalaguda, 150 kms from
Hyderabad
- Has a Reaction Volume Capacity of 700
KL
- Is USFDA Inspected and ISO-9001
certified
- Has achieved 'Zero Discharge'
|
|
Unit 6
- Set up in 1990
- Located at Pydibheemavaram, 800 kms
from Hyderabad
- Has a Reaction Volume Capacity of 570
KL
- Is USFDA Inspected and ISO-9001
certified
|
|
Unit 7
- Our API facility in Mexico gives us niche steroidal API capacities and has the world’s largest capacity for sodium naproxen
|
|
| |
|
Unit 8
- The chiral and biocatalysis technology at the Cambridge facility and the scale up capability in Mirfield adds significant value to the CPS business offerings.
|
|
|
